Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS
Clinical trial NCT04957485 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04957485
- Sponsor
- SIGA Technologies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-05
- Primary completion
- 2027-01-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.